Erik discusses the impact of AI on global medicine, highlighting the challenges faced in developing countries like India due to differences in healthcare practices and drug supply chains. He contrasts the regulatory environments in the US and China, emphasizing the potential for AI to revolutionize healthcare worldwide.
